Creative Planning - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 90 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$125,888
+151.8%
110,428
+653.6%
0.00%
Q1 2021$50,000
-60.9%
14,653
-67.9%
0.00%
Q4 2020$128,000
+276.5%
45,652
+234.4%
0.00%
Q3 2020$34,000
-80.6%
13,652
+6.1%
0.00%
-100.0%
Q2 2020$175,000
+78.6%
12,8700.0%0.00%
Q1 2020$98,000
+21.0%
12,8700.0%0.00%
Q4 2019$81,000
+24.6%
12,870
-22.3%
0.00%
Q3 2019$65,000
-20.7%
16,562
-2.8%
0.00%
Q2 2019$82,000
-42.3%
17,036
-1.8%
0.00%
-100.0%
Q1 2019$142,000
+31.5%
17,343
-11.5%
0.00%
Q4 2018$108,000
+14.9%
19,588
+83.9%
0.00%
Q3 2018$94,000
-11.3%
10,6500.0%0.00%
Q2 2018$106,000
-57.8%
10,650
-59.6%
0.00%
-100.0%
Q1 2018$251,000
+58.9%
26,370
+147.6%
0.00%0.0%
Q4 2017$158,000
-24.4%
10,6500.0%0.00%0.0%
Q3 2017$209,000
+36.6%
10,6500.0%0.00%0.0%
Q2 2017$153,000
+61.1%
10,650
+2.9%
0.00%0.0%
Q1 2017$95,000
-15.9%
10,350
-4.6%
0.00%0.0%
Q4 2016$113,000
-66.6%
10,850
-71.0%
0.00%
-50.0%
Q3 2016$338,000
+21.1%
37,3500.0%0.00%0.0%
Q2 2016$279,000
-38.1%
37,350
-25.3%
0.00%
-50.0%
Q1 2016$451,000
+39.6%
50,000
+100.0%
0.00%
+33.3%
Q4 2015$323,000
+572.9%
25,000
+400.0%
0.00%
Q3 2015$48,0005,0000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders